Patient Preference and Willingness-to-Pay for Humalog Mix25 Relative to Humulin 30/70: A Multicountry Application of a Discrete Choice Experiment
Authors:
- Michael AristidesMAMichael Aristides
- Adèle R. WestonAWAdèle R. Weston
- Patrick FitzGeraldPFPatrick FitzGerald
- Corinne Le ReunCRCorinne Le Reun
- Nikos ManiadakisNMNikos Maniadakis
- 1 July 2004
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 7 (4) , 442-454
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Measuring willingness‐to‐pay for risk reduction: an application of conjoint analysisHealth Economics, 2002
- Conjoint Analysis of a New ChemotherapyPharmacoEconomics, 2002
- Understanding Patient Preferences for the Treatment of Lupus Nephritis With Adaptive Conjoint AnalysisMedical Care, 2001
- The Economic Value of a New Insulin Preparation, Humalog?? Mix 25???PharmacoEconomics, 2000
- Applying conjoint analysis in economic evaluations: an application to menorrhagiaApplied Economics, 2000
- Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro Mix25 and insulin lispro Mix50Clinical Therapeutics, 1999
- A Survey of Methods for Analyzing Clustered Binary Response DataInternational Statistical Review, 1996
- [Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human InsulinDiabetes, 1994
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- Fieller's theorem vs. The delta method for significance intervals for ratiosJournal of Statistical Computation and Simulation, 1975